Atara Biotherapeutics (ATRA) EPS (Basic) Growth (5y) (2018 - 2026)
Atara Biotherapeutics (ATRA) EPS (Basic) Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Atara Biotherapeutics | 140.71 Mn | 124.16 Mn | 439,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 56.77% |
| Mar 31, 2026 | 57.57% |
| Dec 31, 2025 | 60.33% |
| Sep 30, 2025 | 57.51% |
| Jun 30, 2025 | 14.95% |
| Mar 31, 2025 | 16.17% |
| Dec 31, 2024 | 46.38% |
| Sep 30, 2024 | 38.27% |
| Jun 30, 2024 | 40.04% |
| Mar 31, 2024 | 40.65% |
| Dec 31, 2023 | -16.71% |
| Sep 30, 2023 | 12.59% |
| Jun 30, 2023 | 10.01% |
| Mar 31, 2023 | 7.23% |
| Dec 31, 2022 | 9.17% |
| Sep 30, 2022 | 4.26% |
| Jun 30, 2022 | 17.01% |
| Mar 31, 2022 | 0.19% |
| Dec 31, 2021 | -9.49% |
| Sep 30, 2021 | -0.53% |